Walgreens Boots Alliance, Inc. (0LSZ.L)
USD 10.69
(0.56%)
USD 10.69
(0.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 8.32 Billion USD | 0.76% |
| 2023 | 8.25 Billion USD | -1.15% |
| 2022 | 8.35 Billion USD | 2.38% |
| 2021 | 8.15 Billion USD | -13.67% |
| 2020 | 9.45 Billion USD | 1.26% |
| 2019 | 9.33 Billion USD | -2.43% |
| 2018 | 9.56 Billion USD | 7.48% |
| 2017 | 8.89 Billion USD | -0.64% |
| 2016 | 8.95 Billion USD | 3.2% |
| 2015 | 8.67 Billion USD | 42.82% |
| 2014 | 6.07 Billion USD | -11.33% |
| 2013 | 6.85 Billion USD | -2.62% |
| 2012 | 7.03 Billion USD | -12.53% |
| 2011 | 8.04 Billion USD | 9.03% |
| 2010 | 7.37 Billion USD | 8.68% |
| 2009 | 6.78 Billion USD | -6.35% |
| 2008 | 7.24 Billion USD | 6.75% |
| 2007 | 6.79 Billion USD | 12.23% |
| 2006 | 6.05 Billion USD | 8.18% |
| 2005 | 5.59 Billion USD | 18.02% |
| 2004 | 4.73 Billion USD | 12.75% |
| 2003 | 4.2 Billion USD | 15.29% |
| 2002 | 3.64 Billion USD | 4.67% |
| 2001 | 3.48 Billion USD | 23.02% |
| 2000 | 2.83 Billion USD | 14.95% |
| 1999 | 2.46 Billion USD | 21.49% |
| 1998 | 2.02 Billion USD | 16.96% |
| 1997 | 1.73 Billion USD | 6.19% |
| 1996 | 1.63 Billion USD | 12.25% |
| 1995 | 1.45 Billion USD | 15.08% |
| 1994 | 1.26 Billion USD | 15.48% |
| 1993 | 1.09 Billion USD | 10.04% |
| 1992 | 994.2 Million USD | 9.01% |
| 1991 | 912 Million USD | 10.14% |
| 1990 | 828 Million USD | 13.66% |
| 1989 | 728.5 Million USD | 11.15% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 8.57 Billion USD | 0.25% |
| 2024 Q1 | 9.45 Billion USD | 14.5% |
| 2024 Q4 | 8.32 Billion USD | -3.01% |
| 2024 Q2 | 8.55 Billion USD | -9.49% |
| 2023 Q2 | 8.75 Billion USD | -6.06% |
| 2023 FY | 8.25 Billion USD | -1.15% |
| 2023 Q1 | 9.32 Billion USD | 11.6% |
| 2023 Q3 | 8.16 Billion USD | -6.77% |
| 2023 Q4 | 8.25 Billion USD | 1.14% |
| 2022 FY | 8.35 Billion USD | 2.38% |
| 2022 Q4 | 8.35 Billion USD | -1.96% |
| 2022 Q2 | 8.94 Billion USD | -5.57% |
| 2022 Q1 | 9.47 Billion USD | 16.13% |
| 2022 Q3 | 8.52 Billion USD | -4.77% |
| 2021 Q3 | 8.33 Billion USD | -2.44% |
| 2021 Q4 | 8.15 Billion USD | -2.09% |
| 2021 Q1 | 11.18 Billion USD | 18.29% |
| 2021 Q2 | 8.54 Billion USD | -23.6% |
| 2021 FY | 8.15 Billion USD | -13.67% |
| 2020 FY | 9.45 Billion USD | 1.26% |
| 2020 Q1 | 10.53 Billion USD | 12.89% |
| 2020 Q2 | 9.65 Billion USD | -8.39% |
| 2020 Q3 | 9.56 Billion USD | -0.92% |
| 2020 Q4 | 9.45 Billion USD | -1.17% |
| 2019 FY | 9.33 Billion USD | -2.43% |
| 2019 Q3 | 9.87 Billion USD | -3.08% |
| 2019 Q4 | 9.33 Billion USD | -5.48% |
| 2019 Q2 | 10.18 Billion USD | -7.18% |
| 2019 Q1 | 10.97 Billion USD | 14.75% |
| 2018 FY | 9.56 Billion USD | 7.48% |
| 2018 Q1 | 10.01 Billion USD | 12.48% |
| 2018 Q2 | 10.31 Billion USD | 3.06% |
| 2018 Q3 | 9.88 Billion USD | -4.14% |
| 2018 Q4 | 9.56 Billion USD | -3.28% |
| 2017 Q1 | 10.03 Billion USD | 12.09% |
| 2017 FY | 8.89 Billion USD | -0.64% |
| 2017 Q4 | 8.89 Billion USD | 2.51% |
| 2017 Q3 | 8.68 Billion USD | -5.95% |
| 2017 Q2 | 9.23 Billion USD | -8.06% |
| 2016 Q3 | 8.93 Billion USD | -1.04% |
| 2016 Q2 | 9.02 Billion USD | -8.69% |
| 2016 FY | 8.95 Billion USD | 3.2% |
| 2016 Q4 | 8.95 Billion USD | 0.28% |
| 2016 Q1 | 9.88 Billion USD | 13.9% |
| 2015 Q4 | 8.67 Billion USD | -0.98% |
| 2015 Q2 | 9.37 Billion USD | 43.89% |
| 2015 Q1 | 6.51 Billion USD | 7.27% |
| 2015 FY | 8.67 Billion USD | 42.82% |
| 2015 Q3 | 8.76 Billion USD | -6.56% |
| 2014 Q1 | 7.72 Billion USD | 12.8% |
| 2014 Q4 | 6.07 Billion USD | -5.64% |
| 2014 Q3 | 6.43 Billion USD | -10.73% |
| 2014 Q2 | 7.21 Billion USD | -6.68% |
| 2014 FY | 6.07 Billion USD | -11.33% |
| 2013 FY | 6.85 Billion USD | -2.62% |
| 2013 Q4 | 6.85 Billion USD | -0.42% |
| 2013 Q3 | 6.88 Billion USD | -5.13% |
| 2013 Q2 | 7.25 Billion USD | -7.26% |
| 2013 Q1 | 7.82 Billion USD | 11.16% |
| 2012 Q1 | 8.23 Billion USD | 2.32% |
| 2012 FY | 7.03 Billion USD | -12.53% |
| 2012 Q4 | 7.03 Billion USD | 0.46% |
| 2012 Q3 | 7 Billion USD | -4.67% |
| 2012 Q2 | 7.34 Billion USD | -10.74% |
| 2011 Q3 | 7.55 Billion USD | -0.72% |
| 2011 Q4 | 8.04 Billion USD | 6.51% |
| 2011 Q1 | 7.9 Billion USD | 7.2% |
| 2011 Q2 | 7.6 Billion USD | -3.82% |
| 2011 FY | 8.04 Billion USD | 9.03% |
| 2010 Q2 | 7.2 Billion USD | -3.67% |
| 2010 FY | 7.37 Billion USD | 8.68% |
| 2010 Q1 | 7.47 Billion USD | 10.09% |
| 2010 Q4 | 7.37 Billion USD | 3.77% |
| 2010 Q3 | 7.11 Billion USD | -1.25% |
| 2009 Q4 | 6.78 Billion USD | -1.48% |
| 2009 FY | 6.78 Billion USD | -6.35% |
| 2009 Q1 | 8.29 Billion USD | 14.47% |
| 2009 Q2 | 7.58 Billion USD | -8.6% |
| 2009 Q3 | 6.89 Billion USD | -9.14% |
| 2008 Q2 | 7.32 Billion USD | -2.98% |
| 2008 FY | 7.24 Billion USD | 6.75% |
| 2008 Q1 | 7.55 Billion USD | 11.23% |
| 2008 Q3 | 7.06 Billion USD | -3.6% |
| 2008 Q4 | 7.24 Billion USD | 2.62% |
| 2007 Q1 | 6.99 Billion USD | 15.67% |
| 2007 Q2 | 6.53 Billion USD | -6.68% |
| 2007 Q3 | 6.45 Billion USD | -1.16% |
| 2007 Q4 | 6.79 Billion USD | 5.19% |
| 2007 FY | 6.79 Billion USD | 12.23% |
| 2006 Q1 | 6.23 Billion USD | 11.57% |
| 2006 Q3 | 5.54 Billion USD | -1.29% |
| 2006 Q4 | 6.05 Billion USD | 9.14% |
| 2006 FY | 6.05 Billion USD | 8.18% |
| 2006 Q2 | 5.61 Billion USD | -10.0% |
| 2005 Q4 | 5.59 Billion USD | 7.46% |
| 2005 FY | 5.59 Billion USD | 18.02% |
| 2005 Q3 | 5.2 Billion USD | 0.87% |
| 2005 Q2 | 5.15 Billion USD | -7.57% |
| 2005 Q1 | 5.58 Billion USD | 17.81% |
| 2004 Q1 | 4.83 Billion USD | 15.13% |
| 2004 Q2 | 4.51 Billion USD | -6.6% |
| 2004 Q3 | 4.35 Billion USD | -3.53% |
| 2004 FY | 4.73 Billion USD | 12.75% |
| 2004 Q4 | 4.73 Billion USD | 8.69% |
| 2003 Q3 | 4.02 Billion USD | -0.98% |
| 2003 Q2 | 4.06 Billion USD | -1.8% |
| 2003 FY | 4.2 Billion USD | 15.29% |
| 2003 Q1 | 4.13 Billion USD | 13.42% |
| 2003 Q4 | 4.2 Billion USD | 4.54% |
| 2002 FY | 3.64 Billion USD | 4.67% |
| 2002 Q3 | 3.34 Billion USD | -3.83% |
| 2002 Q4 | 3.64 Billion USD | 9.03% |
| 2002 Q1 | 4.02 Billion USD | 15.55% |
| 2002 Q2 | 3.47 Billion USD | -13.61% |
| 2001 Q4 | 3.48 Billion USD | 6.7% |
| 2001 Q3 | 3.26 Billion USD | 1.79% |
| 2001 Q2 | 3.2 Billion USD | -1.67% |
| 2001 FY | 3.48 Billion USD | 23.02% |
| 2001 Q1 | 3.26 Billion USD | 15.19% |
| 2000 Q1 | 2.95 Billion USD | 20.08% |
| 2000 Q2 | 2.63 Billion USD | -10.93% |
| 2000 Q3 | 2.59 Billion USD | -1.47% |
| 2000 FY | 2.83 Billion USD | 14.95% |
| 2000 Q4 | 2.83 Billion USD | 9.08% |
| 1999 Q4 | 2.46 Billion USD | 13.85% |
| 1999 Q1 | 2.23 Billion USD | 10.41% |
| 1999 FY | 2.46 Billion USD | 21.49% |
| 1999 Q2 | 2.13 Billion USD | -4.39% |
| 1999 Q3 | 2.16 Billion USD | 1.08% |
| 1998 FY | 2.02 Billion USD | 16.96% |
| 1998 Q1 | 2.06 Billion USD | 18.98% |
| 1998 Q2 | 1.93 Billion USD | -5.97% |
| 1998 Q3 | 1.83 Billion USD | -5.21% |
| 1998 Q4 | 2.02 Billion USD | 10.28% |
| 1997 Q1 | 1.84 Billion USD | 13.08% |
| 1997 Q2 | 1.71 Billion USD | -6.95% |
| 1997 Q3 | 1.65 Billion USD | -3.8% |
| 1997 Q4 | 1.73 Billion USD | 4.91% |
| 1997 FY | 1.73 Billion USD | 6.19% |
| 1996 Q4 | 1.63 Billion USD | 6.53% |
| 1996 Q2 | 1.58 Billion USD | -4.51% |
| 1996 Q1 | 1.66 Billion USD | 14.51% |
| 1996 FY | 1.63 Billion USD | 12.25% |
| 1996 Q3 | 1.53 Billion USD | -3.64% |
| 1995 Q1 | 1.48 Billion USD | 17.33% |
| 1995 Q3 | 1.34 Billion USD | 0.67% |
| 1995 Q2 | 1.33 Billion USD | -10.18% |
| 1995 Q4 | 1.45 Billion USD | 8.48% |
| 1995 FY | 1.45 Billion USD | 15.08% |
| 1994 Q2 | 1.19 Billion USD | -6.27% |
| 1994 Q4 | 1.26 Billion USD | 12.58% |
| 1994 Q3 | 1.12 Billion USD | -5.78% |
| 1994 FY | 1.26 Billion USD | 15.48% |
| 1994 Q1 | 1.27 Billion USD | 16.16% |
| 1993 Q1 | 1.15 Billion USD | 16.36% |
| 1993 Q4 | 1.09 Billion USD | 7.09% |
| 1993 Q3 | 1.02 Billion USD | -1.34% |
| 1993 FY | 1.09 Billion USD | 10.04% |
| 1993 Q2 | 1.03 Billion USD | -10.49% |
| 1992 FY | 994.2 Million USD | 9.01% |
| 1992 Q1 | 1.06 Billion USD | 16.52% |
| 1992 Q2 | 964.4 Million USD | -9.25% |
| 1992 Q3 | 923.3 Million USD | -4.26% |
| 1992 Q4 | 994.2 Million USD | 7.68% |
| 1991 Q3 | 864 Million USD | 1.59% |
| 1991 Q1 | 958 Million USD | 15.7% |
| 1991 FY | 912 Million USD | 10.14% |
| 1991 Q2 | 850.5 Million USD | -11.22% |
| 1991 Q4 | 912 Million USD | 5.56% |
| 1990 Q4 | 828 Million USD | 7.07% |
| 1990 FY | 828 Million USD | 13.66% |
| 1990 Q3 | 773.3 Million USD | -1.55% |
| 1990 Q2 | 785.5 Million USD | -11.61% |
| 1990 Q1 | 888.7 Million USD | 21.99% |
| 1989 FY | 728.5 Million USD | 11.15% |
| 1989 Q4 | 728.5 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| uniQure N.V. | 12.02 Million USD | -69094.943% |
| Agios Pharmaceuticals, Inc. | 19.07 Million USD | -43515.014% |
| Amicus Therapeutics, Inc. | 59.69 Million USD | -13837.282% |
| Atara Biotherapeutics, Inc. | 9.7 Million USD | -85620.173% |
| bluebird bio, Inc. | 22.91 Million USD | -36201.758% |
| Cara Therapeutics, Inc. | 2.82 Million USD | -294830.876% |
| Imunon, Inc. | - USD | -Infinity% |
| Editas Medicine, Inc. | - USD | -Infinity% |
| IQVIA Holdings Inc. | - USD | -Infinity% |
| Mettler-Toledo International Inc. | 385.86 Million USD | -2056.195% |
| Myriad Genetics, Inc. | 20.1 Million USD | -41293.035% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -21623.238% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -10648.243% |
| Verastem, Inc. | - USD | -Infinity% |
| Waters Corporation | 516.23 Million USD | -1511.666% |
| Thermo Fisher Scientific Inc. | 5.08 Billion USD | -63.522% |
| Biogen Inc. | 2.52 Billion USD | -229.192% |
| Nektar Therapeutics | 16.1 Million USD | -51573.809% |
| Perrigo Company plc | 1.14 Billion USD | -629.249% |
| Dynavax Technologies Corporation | 53.29 Million USD | -15512.685% |
| Illumina, Inc. | 587 Million USD | -1317.376% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 10.37 Million USD | -80115.966% |
| Heron Therapeutics, Inc. | 42.11 Million USD | -19657.777% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.1 Billion USD | -651.457% |
| Sangamo Therapeutics, Inc. | - USD | -Infinity% |
| Evolus, Inc. | 10.99 Million USD | -75550.118% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.58 Billion USD | -222.418% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -12578.482% |
| FibroGen, Inc. | 41.56 Million USD | -19916.841% |
| Agilent Technologies, Inc. | 1.03 Billion USD | -706.984% |
| OPKO Health, Inc. | 65.69 Million USD | -12564.201% |
| Homology Medicines, Inc. | - USD | -Infinity% |
| Geron Corporation | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 89.14 Million USD | -9233.004% |
| Exelixis, Inc. | 17.32 Million USD | -47928.632% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | - USD | -Infinity% |
| Zoetis Inc. | 2.56 Billion USD | -224.493% |
| Axsome Therapeutics, Inc. | 15.13 Million USD | -54871.919% |
| Abeona Therapeutics Inc. | -2.44 Million USD | 340525.532% |
| Vertex Pharmaceuticals Incorporated | 738.8 Million USD | -1026.151% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 28.42 Million USD | -29170.009% |
| Sarepta Therapeutics, Inc. | 322.85 Million USD | -2476.976% |
| Corcept Therapeutics Incorporated | 7.73 Million USD | -107532.6% |
| Halozyme Therapeutics, Inc. | 127.6 Million USD | -6420.325% |
| Blueprint Medicines Corporation | 21.22 Million USD | -39102.752% |
| Insmed Incorporated | 83.24 Million USD | -9894.234% |
| TG Therapeutics, Inc. | 39.82 Million USD | -20792.449% |
| Incyte Corporation | 62.97 Million USD | -13112.221% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -2429.644% |